Active
Standard
Most Recent
ANSI/AAMI/ISO 13022:2012
Medical products containing viable human cells—Application of risk management and requirements for processing practices
Summary
Specifies a procedure to identify the hazards and hazardous situations and to manage the risk associated with viable cellular component(s) of products regulated as medicinal products, biologics, medical devices and active implantable medical devices or combinations thereof. Covers viable human materials of autologous as well as allogeneic human origin. Annex 3
Technical characteristics
| Publisher | Association for the Advancement of Medical Instrumentation (AAMI) |
| Publication Date | 01/01/2012 |
| Page Count | 0 |
| Themes | Biological Evaluation |
| EAN | --- |
| ISBN | --- |
| Weight (in grams) | --- |
No products.